Page last updated: 2024-08-26

imipenem, anhydrous and Carcinoma, Large Cell

imipenem, anhydrous has been researched along with Carcinoma, Large Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, N; Hiratsuka, M; Ichikawa, Y; Ishibashi, T; Kido, M; Kondo, Y; Kuroki, S; Kusano, T; Mitsuyama, T; Miyahara, T; Motohiro, A; Nakanishi, Y; Naoe, H; Nikaido, Y; Ninomiya, K; Ohno, T; Oizumi, K; Senju, S; Shigematsu, H; Takamoto, M; Tanaka, H; Ueda, H; Watanabe, K; Yamada, H; Yoshida, M1

Trials

1 trial(s) available for imipenem, anhydrous and Carcinoma, Large Cell

ArticleYear
[Clinical efficacy of imipenem/cilastatin sodium for respiratory infections in patients with lung cancer].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Opportunistic Infections; Respiratory Tract Infections

1997